Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.
Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.
复制标题
DOI:
10.1097/fbp.0000000000000012
复制
发表时间:
2014-02
影响因子:
1.6
通讯作者:
Translational Methamphetamine AIDS Research Center (TMARC) Group
中科院分区:
文献类型:
--
作者:
Henry BL;Geyer MA;Buell MR;Perry W;Young JW;Minassian A;Translational Methamphetamine AIDS Research Center (TMARC) Group
HIV infection is frequently comorbid with methamphetamine (METH) dependence. Both factors are associated with impairment in inhibitory function that continues even after abstinence from the drug. Deficits in prepulse inhibition (PPI), a measure of sensorimotor gating, are induced by acute stimulant administration, but the combined effect of HIV and chronic METH exposure on PPI is not well characterized. We quantified baseline acoustic startle and PPI in mice expressing the HIV-1 gp120 envelope protein (gp120tg) and in wild-type (WT) littermates; thereafter, we administered a chronic regimen of METH or vehicle and tested startle and PPI after 7 days of drug withdrawal. We hypothesized that METH-treated gp120tg mice would exhibit PPI deficits compared with vehicle-treated WT or gp120tg animals. Before METH administration, drug-naive female gp120tg mice exhibited decreased PPI compared with female WT mice, whereas male gp120tg mice exhibited increased startle compared with other groups. After drug withdrawal, no consistent genotype effect was observed, but METH-treated mice exhibited increased PPI compared with vehicle, in contrast to previous reports of acute METH-induced PPI deficits. In summary, PPI impairment in HIV could depend on factors such as sex, whereas changes in PPI following METH withdrawal may depend on the quantity and duration of drug exposure.